Nac Al (Acetylcysteine)

Acetylcysteine, the active ingredient in Nac Al, is a mucolytic agent presented as an oral dosage form for oral use. It is employed to thin respiratory mucus in conditions such as chronic bronchitis, chronic obstructive pulmonary disease (COPD) and sinusitis, primarily in adult patients.

GNH USA supplies Nac Al as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance. The company adheres to Good Distribution Practice standards and provides reliable logistics for cross‑border shipments.

Acetylcysteine is a mucolytic that reduces mucus viscosity in several respiratory disorders.

Chronic bronchitis: improves sputum clearance and eases cough by thinning airway secretions. COPD: enhances mucociliary transport, helping reduce exacerbation frequency. Sinusitis: facilitates drainage of thick nasal mucus, relieving congestion. Bronchiectasis: assists in clearing persistent mucus, decreasing infection risk. Acute respiratory infections: shortens duration of productive cough by loosening secretions. Post‑operative pulmonary care: reduces risk of atelectasis by promoting airway clearance. Cystic fibrosis (adjunct): may improve mucus clearance when used as part of combination therapy.

Acetylcysteine may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea - Vomiting - Diarrhea - Abdominal discomfort - Rash - Metallic taste

Serious or Rare Side Effects: - Anaphylaxis - Severe skin reactions (e.g., Stevens‑Johnson syndrome) - Bronchospasm - Hepatic dysfunction - Neutropenia - Angioedema

When prescribing acetylcysteine, clinicians should consider several safety measures.

Assess renal and hepatic function: evaluate before initiating therapy. Monitor for allergic reactions: watch for rash, itching or swelling. Use cautiously in asthma: may provoke bronchospasm. Adjust dose in renal impairment: consider reduced dosing. Avoid in patients with known hypersensitivity to acetylcysteine. Store at ambient temperature: keep in the original container, protect from moisture.

Acetylcysteine can interact with other medicines; some combinations should be avoided while others require monitoring.

Major Interactions (Avoid): - Nitroglycerin: may cause additive hypotensive effects. - Activated charcoal: reduces oral absorption of acetylcysteine. - Certain chemotherapeutic agents (e.g., cyclophosphamide): may increase toxicity.

Moderate Interactions (Monitor Closely): - Penicillins: increased risk of rash. - ACE inhibitors: possible additive blood‑pressure lowering. - Oral contraceptives: may reduce hormonal efficacy.